|
Published by: Decision Resources
Published: Feb. 21, 2008 - 28 Pages
Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview of the Diagnostic Imaging Market
- Key Diagnostic Imaging Technologies
- X Ray
- Computed Tomography
- Magnetic Resonance Imaging
- Nuclear Medicine Imaging
- Single-Photon-Electron-Computed Tomography
- Positron-Emission Tomography
- Ultrasound
- Opportunities for Industry Growth
- Improving Clinical Applications
- Developing Hybrid Modalities
- PET/CT
- SPECT/CT
- MRI/PET
- Improving Imaging Agents
- Advances in Information Technology
- Picture Archiving and Communication System
- Computer-Aided Detection/Diagnosis
- Exploiting Nanotechnology
- Key Challenges Faced by the Industry
- Issues of Reimbursement
- More Approvals for Tracer Agents
- Company Profiles
- GE Healthcare
- Siemens Medical Solutions
- Philips Medical Systems
- Outlook
- Appendix A. Imaging Agents in Clinical Development
- Tables
- 1. Advantages and Disadvantages of Major Diagnostic Imaging Modalities
- 2. Select 99mTc Radiopharmaceuticals in Clinical Application
- 3. Diagnostic Imaging Collaborations of GE Healthcare, 2000-Present
- 4. Diagnostic Imaging Collaborations of Siemens Medical Solutions, 2000-Present
- 5. Diagnostic Imaging Collaborations of Philips Medical Systems, 2000-Present
- 6. Trends That Companies Should Heed for Future Success
- Figures
- 1. The U.S. Diagnostic Imaging Market, 2005-2011
- 2. Market Value of Major Diagnostic Imaging Modalities, United States, 2005-2011
- 3. Clinical Applications of Diagnostic Imaging Techniques
- 4. Worldwide Revenues for Imaging Agents, 2007-2012
- 5. Leading Companies in the U.S. Diagnostic Imaging Market, 2006
- 6. Comparison of Leading Companies by Diagnostic Imaging Modality, United States, 2006
AbstractIntroduction
Scientific and technological developments are making the field of diagnostic imaging a growth industry.
In 2007, the U.S. market for diagnostic imaging technologies was valued at more than $7 billion, and it is
expected to exceed $8 billion by 2011. There are several trends that companies must heed to enjoy success in
this market.
Get the Answers You Need to Shape Your Strategy
- Diagnostic imaging comprises five major modalities: magnetic resonance imaging (MRI), ultrasound, X ray, computed tomography (CT), and nuclear medicine (i.e., single-photon-emission-computed tomography [SPECT] and positron-emission tomography [PET]).
What is the value of each of these fields today, and what are their growth prospects through 2011?
- Opportunities for growth in the industry are varied.
One area is the development of hybrid modalities to combat competition and provide a more comprehensive and accurate diagnostic image.
What hybrids have been developed, and which ones are still at the development stage?
What are their respective advantages in the clinic?
- The diagnostic imaging market faces two key challenges.
What are these challenges, and how might the industry address them?
Scope
- The major diagnostic imaging modalities: magnetic resonance imaging (MRI), ultrasound, X ray, computed tomography (CT), and nuclear medicine (i.e., single-photon-emission-computed tomography [SPECT] and positron-emission tomography [PET]).
- Opportunities for industry growth: improving clinical applications, developing hybrid modalities, advances in information technology, and exploiting nanotechnology.
- The top three companies in the diagnostic imaging market: GE Healthcare, Siemens Healthcare Solutions, and Philips Medical Systems.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|
